IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

TICOZZI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.602
NA - Nord America 5.173
AS - Asia 3.734
SA - Sud America 370
OC - Oceania 91
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.017
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.916
DE - Germania 2.848
IT - Italia 2.344
GB - Regno Unito 1.822
CN - Cina 1.603
SG - Singapore 1.005
SE - Svezia 585
RU - Federazione Russa 445
IN - India 333
IE - Irlanda 320
BR - Brasile 285
CA - Canada 233
KR - Corea 188
UA - Ucraina 179
FI - Finlandia 178
NL - Olanda 171
FR - Francia 158
ID - Indonesia 151
TR - Turchia 133
DK - Danimarca 113
HK - Hong Kong 110
ES - Italia 97
AU - Australia 81
JP - Giappone 75
EU - Europa 62
BE - Belgio 56
PL - Polonia 47
CH - Svizzera 44
CO - Colombia 43
AT - Austria 36
GR - Grecia 33
RO - Romania 21
CZ - Repubblica Ceca 18
TW - Taiwan 17
PT - Portogallo 16
VN - Vietnam 16
NO - Norvegia 15
PH - Filippine 14
CL - Cile 13
IR - Iran 13
MX - Messico 12
HU - Ungheria 10
NZ - Nuova Zelanda 10
EG - Egitto 9
UZ - Uzbekistan 9
EC - Ecuador 8
NP - Nepal 8
SC - Seychelles 8
TN - Tunisia 8
IQ - Iraq 7
PK - Pakistan 7
BG - Bulgaria 6
LT - Lituania 6
PE - Perù 6
VE - Venezuela 6
EE - Estonia 5
JO - Giordania 5
LB - Libano 5
LI - Liechtenstein 5
MA - Marocco 5
SA - Arabia Saudita 5
TH - Thailandia 5
AR - Argentina 4
HR - Croazia 4
LV - Lettonia 4
CY - Cipro 3
GE - Georgia 3
GH - Ghana 3
LU - Lussemburgo 3
MD - Moldavia 3
PA - Panama 3
RS - Serbia 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
ZA - Sudafrica 3
AL - Albania 2
AM - Armenia 2
BS - Bahamas 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
IS - Islanda 2
JM - Giamaica 2
KZ - Kazakistan 2
MM - Myanmar 2
MY - Malesia 2
OM - Oman 2
AE - Emirati Arabi Uniti 1
AN - Antille olandesi 1
AO - Angola 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
BZ - Belize 1
DZ - Algeria 1
FO - Isole Faroe 1
GA - Gabon 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 19.071
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 2.064
Southend 1.497
Milan 740
Singapore 662
Chandler 521
Dublin 317
Seattle 311
Beijing 264
Ashburn 251
Princeton 247
Council Bluffs 245
Fairfield 240
Hanover 240
Wilmington 200
Ann Arbor 190
Toronto 165
Jakarta 145
Dearborn 139
Houston 130
Woodbridge 130
Bengaluru 121
Nanjing 120
Santa Clara 120
Jacksonville 113
Rome 100
Des Moines 98
Boardman 88
Redmond 83
Shanghai 79
Helsinki 72
Cambridge 71
Mountain View 68
Hong Kong 67
New York 65
Nuremberg 56
Serra 55
Los Angeles 52
Turin 52
Guangzhou 51
Jinan 50
Redwood City 47
Sakarya 47
Somerville 46
Berlin 42
Changsha 41
Fuzhou 41
Nanchang 41
Brussels 40
Phoenix 40
Bogotá 38
Warsaw 37
Shenyang 36
Andover 35
London 35
San Diego 33
Kent 32
Lappeenranta 32
Munich 29
São Paulo 28
Yongin-si 28
Hangzhou 27
Athens 26
Chengdu 26
Hebei 26
Norwalk 25
Ottawa 25
Wuhan 25
Tianjin 24
Florence 23
Silver Spring 23
Chicago 22
Jiaxing 21
Margão 21
Utebo 21
Naples 20
Bologna 19
Brescia 19
Eitensheim 18
Hyderabad 18
Monza 18
Pisa 18
Zhengzhou 18
Medford 17
Padova 17
Tokyo 17
Bühl 16
Fremont 16
Genoa 16
Bergamo 15
Pune 15
Vienna 15
Hamburg 14
Zurich 14
Amsterdam 13
Bari 13
Quanzhou 13
Rho 13
Rio de Janeiro 13
Seoul 13
Falkenstein 12
Totale 11.772
Salva come PNG Salva come JPEG
Nome #
The diagnosis of Amyotrophic Lateral Sclerosis 344
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 343
TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients 330
Cerebrospinal fluid phosphorylated neurofilament heavy chain and chitotriosidase in primary lateral sclerosis 258
Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis 245
Standardization of the Italian ALS-CBS™ Caregiver Behavioral Questionnaire 230
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis 228
ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function 226
Brain-Computer Interface for Clinical Purposes : Cognitive Assessment and Rehabilitation 214
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 211
La diagnosi di Sclerosi Laterale Amiotrofica(SLA): 2009 207
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia 207
The complex interplay between depression/anxiety and executive functioning : insights from the ECAS in a large ALS Population 205
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 204
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia 191
Diagnostic properties of the Italian ECAS Carer Interview (ECAS-CI) 189
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis 186
The Arrows and Colors Cognitive Test (ACCT) : a new verbal-motor free cognitive measure for executive functions in ALS 185
Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations 169
Attachment, personality and locus of control : psychological determinants of risk perception and preventive behaviors for COVID-19 167
The validation of the Italian Edinburgh cognitive and behavioural ALS screen (ECAS) 166
Response to the commentary “The effect of C9orf72 intermediate repeat expansions in neurodegenerative and autoimmune diseases” by Biasiotto G and Zanella I. 163
Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients 160
Identification of Angiogenin gene mutations in a large cohort of Italian ALS patients 156
Angiogenin: a novel candidate gene for ALS pathogenesis in the Italian Population 152
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways 151
Muscle mitochondrial oxidative defects in Amyotrophic Lateral Scelosis 149
A novel nonsense ATP7A pathogenic variant in a family exhibiting a variable occipital horn syndrome phenotype 145
C9ORF72 repeat expansion in a large Italian ALS cohort : evidence of a founder effect 144
Shaping the Neurovascular Unit Exploiting Human Brain Organoids 139
Genetic variation in DPP6 gene is not associated with susceptibility to Amyotrophic Lateral Sclerosis in two European population 139
Identification of new HSPB8 variants linked to familial Amiotrophic Lateral Sclerosis 139
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 137
Cognitive-behavioral longitudinal assessment in ALS : the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS) 136
SOD1 Gene mutations in Italian Amyotrophic Lateral Sclerosis Patients 135
Diagnostics and clinical usability of the Montreal Cognitive Assessment (MoCA) in amyotrophic lateral sclerosis 134
ALS Genes: mutational analysis in a large cohort of Italian patients 134
An eye-tracking controlled neuropsychological battery for cognitive assessment in neurological diseases 134
Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis 133
Genetics of Familial Amyotrophic Lateral Sclerosis 133
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 131
The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1 130
Analysis of FUS Gene Mutation in Familial Amyotrophic Lateral Sclerosis within an Italian cohort 128
Identification of new ANG gene mutations in a large cohort of Italian patients with Amyotrophic Lateral Sclerosis 127
ALS genes: a mutational screening in a large cohort of Italian patients 126
Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis 126
Testing olfactory dysfunction in acute and recovered COVID-19 patients: a single center study in Italy 125
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis : identification of novel mutations 122
The Effects of a New Integrated and Multidisciplinary Cognitive Rehabilitation Program Based on Mindfulness and Reminiscence Therapy in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Pilot Study 121
One‐Year Cognitive Follow‐Up of COVID‐19 Hospitalized Patients 121
Mutation analysis of the VPS54 gene in ALS patients 120
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis 120
Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients 119
Clinical usability of the Story-Based Empathy Task (SET) in non-demented ALS patients 119
Angiogenin gene mutations in Italian patients with familial and sporadic ALS 118
Reduced expression of the kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic Amyotrophic Lateral Sclerosis 117
Ubiquilin 2 mutations in Italians patients with amyotrophic lateral sclerosis and frontotemporal dementia 117
Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia 115
CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis 114
High frequency of TARDBP gene mutations in Italian patients with Amyotrophic Lateral Sclerosis 113
Paraoxonase gene mutations in amyotrophic lateral sclerosis 113
Protein aggregation and defective RNA metabolism as mechanisms for motor neuron damage 112
C9orf72 repeat expansions are restricted to the ALS-FTD spectrum 112
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 112
PON1 is a disease modifier gene in amyotrophic lateral sclerosis : association of the Q192R polymorphism with bulbar onset and reduced survival 112
Cognitive assessment in Amyotrophic Lateral Sclerosis by means of P300-Brain Computer Interface : a preliminary study 112
CSF angiogenin levels in amyotrophic lateral Sclerosis-Frontotemporal dementia spectrum 111
Verbal Learning Impairment in Parkinson's Disease: Role of the Frontostriatal System in Working and Strategic Memory 110
Emotional and autonomic response to visual erotic stimulation in patients with functional hypothalamic amenorrhea 109
Central dysgraphic pattern in a patient with Foix-Chavany-Marie Syndrome: case report 109
Diagnostic properties of the Frontal Assessment Battery (FAB) in Huntington’s disease 108
Mutational analysis of TARDP in neurodegenerative diseases 108
Sexuality and intimacy in ALS: systematic literature review and future perspectives 108
TMEM106B Acts as a Modifier of Cognitive and Motor Functions in Amyotrophic Lateral Sclerosis 107
No C9orf72 repeat expansion in patients with primary progressive multiple sclerosis 107
Stem cells and other perspective reparative-regenerative strategies in ALS 105
Identification of FUS/TLS Gene mutations in a cohort of Italian FALS patients 105
Lower semantic fluency scores and a phonemic-over-semantic advantage predict abnormal CSF P-tau181 levels in Aβ + patients within the Alzheimer's disease clinical spectrum 104
Concurrence of SOD1 and ANG mutations in an Italian ALS family 104
Role of expectations in clinical outcomes after deep brain stimulation in patients with Parkinson's disease: a systematic review 103
Identification of FUS/TLS gene mutation in a cohort of Italian FALS patients 103
Recenti sviluppi nella genetica della Sclerosi Laterale Amiotrofica 103
Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients 102
Concurrence of SOD1 and ANG Mutations in Italian ALS Family 102
RNA-binding proteins and RNA metabolism : a new scenario in the pathogenesis of Amyotrophic Lateral Sclerosis 102
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS 102
Association of the risk factor UNC13A with survival and upper motor neuron involvement in amyotrophic lateral sclerosis 101
Ecological Validity of the Montreal Cognitive Assessment in Non-Demented Parkinson's Disease Patients 101
Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis 101
Prevalence and determinants of language impairment in non-demented amyotrophic lateral sclerosis patients 101
CSF Aβ40 and P-tau181 might differentiate atypical from typical AD phenotypes : preliminary evidence 99
The Frontal Assessment Battery (FAB) effectively discriminates between MCI and dementia within the clinical spectrum of neurochemically confirmed Alzheimer’s disease 99
Bulbar involvement and cognitive features in amyotrophic lateral sclerosis: a retrospective study on 347 patients 99
Optineurin gene mutations in a color of Italian amyotrophic lateral sclerosis patients 99
Elevated global DNA methylation is not exclusive to amyotrophic lateral sclerosis and is also observed in spinocerebellar ataxia types 1 and 2 99
Unleashing the potential of mRNA therapeutics for inherited neurological diseases 98
Novel optineurin mutations in patients with familial and sporadic Amyotrophic Lateral Sclerosis 98
The impact of upper motor neuron involvement on clinical features, disease progression and prognosis in amyotrophic lateral sclerosis 97
Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis 97
Pramipexole treatment in a late-onset Huntington's disease patient 97
Totale 14.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020422 0 0 0 0 0 0 0 0 0 214 136 72
2020/20211.538 147 117 124 64 153 117 133 85 106 150 261 81
2021/20221.961 73 80 84 127 206 126 198 114 292 227 126 308
2022/20232.433 244 216 187 184 244 419 104 133 291 65 197 149
2023/20244.078 145 171 131 304 701 277 398 366 184 366 493 542
2024/20254.400 477 719 415 628 325 295 420 641 454 26 0 0
Totale 20.225